Reid Hoffmans bold $24.6 million bet on an AI cancer research startup could be the catalyst that transforms how scientists detect, predict, and treat one of the worlds deadliest diseases. Discover how cutting-edge machine learning is rewriting the rules of cancer research — and why Silicon Valleys most visionary investor is all in.
Read more
